Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Hallucinations and CYP2D6[original query] |
|---|
| The relationship between the response of clinical symptoms and plasma olanzapine concentration, based on pharmacogenetics: Juntendo University Schizophrenia Projects (JUSP). Therapeutic drug monitoring 2008 Feb 30 (1): 35-40. Nozawa Motohiro, Ohnuma Tohru, Matsubara Yoichiro, Sakai Yoshie, Hatano Tokiko, Hanzawa Ryo, Shibata Nobuto, Arai He |
| Effect of Routine Cytochrome P450 2D6 and 2C19 Genotyping on Antipsychotic Drug Persistence in Patients With Schizophrenia: A Randomized Clinical Trial. JAMA network open 2020 12 3 (12): e2027909. Jürgens Gesche, Andersen Stig E, Rasmussen Henrik B, Werge Thomas, Jensen Heidi D, Kaas-Hansen Benjamin Skov, Nordentoft Mere |
| GENETIC VARIANTS IN ANTIPSYCHOTIC METABOLISM: POLYMORPHISM PROFILES IN KAZAKH COHORT WITH PARANOID SCHIZOPHRENIA. Georgian medical news 2024 12 (355): 99-103. K Kovaleva, Z Kachiyeva, A Abetova, N Raspopo |
| Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers. Psychopharmacology bulletin 2025 1 55 (1): 37-46. VYu Skryabin, A E Petukhov, S A Pozdniakov, V A Ivanchenko, I A Zaytsev, S S Miroshkin, S I Sokolova, I V Bure, V V Smirnov, D A Sych |
- Page last reviewed:Feb 1, 2024
- Content source:

